Results 121 to 130 of about 28,587 (260)
Current management of acute bronchiolitis in Switzerland
Swiss Medical Weekly, 2003 Swiss Medical Weekly
doaj +1 more source
Inhaled bronchodilators and the risk of tachyarrhythmias
, 2015 Background/objectives: There have been controversies about whether inhaled bronchodilators could increase the risk of clinically important tachyarrhythmias.
Kim, Deog Kyeom +8 more
core +1 more source
Work‐Related Asthma From Exposure to Cardboard and Paper Products
American Journal of Industrial Medicine, Volume 69, Issue 6, Page 482-488, June 2026.ABSTRACT Background We assess the contribution of cardboard dust exposure to the development of work‐related asthma (WRA). Prior studies on paper‐dust‐related breathing problems have focused on exposures in the paper milling and pulp industries. There have been no reports of asthma linked to workplace exposure to cardboard dust.
Mason E. Glanville +2 more
wiley +1 more source
, 2017 Background: Cardiovascular disease (CVD) is the most prevalent comorbidity for chronic obstructive pulmonary disease (COPD). Potential adverse cardiovascular events of bronchodilators warrant their cautionary use in the comorbid COPD-CVD population, yet
Cynthia J. Willey, Damilola T. Adesanoye
core +1 more source
International Forum of Allergy &Rhinology, Volume 16, Issue 6, Page 615-629, June 2026.ABSTRACT Background Remission, a term used to describe a goal of treatment for some chronic diseases, has recently been proposed for chronic rhinosinusitis (CRS). However, it is unclear what remission means for CRS and why it should serve as a goal in the present‐day treatment of CRS.
Nikhil Parail +7 more
wiley +1 more source
International Journal of COPD, 2020 Tanja Plate,1 Felix W Friedrich,1 Jutta Beier2 1AstraZeneca GmbH, Wedel, Germany; 2Insaf - Respiratory Research Institute GmbH, Wiesbaden, GermanyCorrespondence: Felix W FriedrichAstraZeneca GmbH, Tinsdaler Weg 183, Wedel D-22880, GermanyTel +49 162 ...
Plate T, Friedrich FW, Beier J
doaj
Effect of bronchodilators in healthy individuals receiving lumacaftor/ivacaftor combination therapy
, 2016 In an open-label, single-center phase 1 pharmacokinetic study in healthy subjects who received lumacaftor (LUM) in combination with ivacaftor (IVA), review of spirometry data showed a transient decline in percent predicted forced expiratory volume in 1s (
Waltz, David +2 more
core +1 more source
British Journal of Clinical Pharmacology, Volume 92, Issue 6, Page 1787-1808, June 2026.Aims Prescribing is a complex, essential skill that doctors must acquire to practice medicine safely and effectively. The British Pharmacological Society has historically provided a core curriculum to guide clinical pharmacology and prescribing education in UK medical schools.
Dagan O. Lonsdale +5 more
wiley +1 more source
, 2007 SummaryBoth oxygen therapy and bronchodilators reduce exertional breathlessness and improve exercise tolerance in patients with stable chronic obstructive pulmonary disease (COPD).
Calverley, Peter M.A. +11 more
core +1 more source
Clinical Case Reports, Volume 14, Issue 6, June 2026.ABSTRACT Paraneoplastic pemphigus (PNP) is a life‐threatening autoimmune blistering disease with a mortality rate of 70%–90%, driven largely by respiratory complications such as bronchiolitis obliterans. Managing respiratory failure in these patients remains exceptionally difficult.
Lu Li +5 more
wiley +1 more source